Literature DB >> 2303363

Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I.

B G Sorbe1, A C Smeds.   

Abstract

A high dose rate (60Co) afterloading technique was used for postoperative prophylactic vaginal irradiation in a series of 404 women with endometrial carcinoma Stage I. The total recurrence rate was 3.7% with 0.7% vaginal deposits. The crude 5-year survival rate for the complete series was 91.8% compared to 13.3% for those with recurrences. Depth of myometrial infiltration (greater than 1/3 of the uterine wall) and nuclear grade were the most important prognostic factors. Clinically significant late radiation reactions (bladder and/or rectum) were recorded in 6.9%. Dose per fraction and the size of the target volume were highly significantly related to the occurrence of both early and late radiation reactions. Vaginal shortening is closely related to the dose per fraction, length of the reference isodose, and the applicator diameter. The shape of the vaginal applicator versus the isodoses and the importance of the source train geometry and relative activity for dose gradient inhomogeneities within the target volume are discussed. Cumulative radiation effect (CRE) and linear-quadratic (LQ) calculations have been performed and related to tissue reactions within the target volume and in the risk organs. An alpha-beta quotient of 8.8 for vaginal shrinkage effect and 2.0 for late rectal complications are suggested on the basis of calculations using a maximum likelihood method for quantal radiation data.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303363     DOI: 10.1016/0360-3016(90)90094-z

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.

Authors:  Matthew M Harkenrider; Alec M Block; Kaled M Alektiar; David K Gaffney; Ellen Jones; Ann Klopp; Akila N Viswanathan; William Small
Journal:  Brachytherapy       Date:  2016-05-31       Impact factor: 2.362

2.  Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.

Authors:  John M Stahl; Jack M Qian; Christopher J Tien; David J Carlson; Zhe Chen; Elena S Ratner; Henry S Park; Shari Damast
Journal:  Support Care Cancer       Date:  2018-09-05       Impact factor: 3.603

3.  Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma.

Authors:  Angeles Rovirosa; Izaskun Valduvieco; Carlos Ascaso; Antonio Herreros; Carlos Bautista; Ingrid Romera; Meritxell Arenas; Jaume Pahisa; Albert Biete
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

Review 4.  Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?

Authors:  Sebastià Sabater; Ignacio Andres; Veronica Lopez-Honrubia; Roberto Berenguer; Marimar Sevillano; Esther Jimenez-Jimenez; Angeles Rovirosa; Meritxell Arenas
Journal:  Cancer Manag Res       Date:  2017-08-09       Impact factor: 3.989

5.  Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer.

Authors:  Farnaz Amouzegar Hashemi; Zakieh Vesgari Kiasari; Bita Kalaghchi; Mahdi Aghili; Soraya Gholami; Sepideh Mansouri; Sepand Moalej; Afsaneh Maddah Safaei
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

6.  Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer.

Authors:  Melis Gultekin; Melek Tugce Yilmaz; Fatih Biltekin; Deniz Yuce; Sezin Yuce Sari; Fadil Akyol; Ferah Yildiz
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

7.  Dosimetric comparison of two afterloaders and treatment planning systems in vaginal high-dose-rate brachytherapy.

Authors:  Deborah C Marshall; Julie R Bloom; Zahra Ghiassi-Nejad; Vishal Gupta; Audrey Saitta; Allison Powers; Ren-Dih Sheu; Yeh-Chi Lo; Vishruta Dumane
Journal:  J Contemp Brachytherapy       Date:  2022-08-08

8.  Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?

Authors:  Garrett L Jensen; Parul N Barry; Harriet Eldredge-Hindy; Scott R Silva; Sarah L Todd; Kendall P Hammonds; Walker R Zimmerman; Daniel S Metzinger; Moataz N El-Ghamry
Journal:  J Contemp Brachytherapy       Date:  2021-05-07

9.  Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer.

Authors:  Jack M Qian; John M Stahl; Melissa R Young; Elena Ratner; Shari Damast
Journal:  J Gynecol Oncol       Date:  2017-11       Impact factor: 4.401

10.  Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction(α/β=3Gy) at 2 cm3 of vagina.

Authors:  María Del Valle Aguilera; Ángeles Rovirosa; Carlos Ascaso; Antonio Herreros; Joan Sánchez; Julia Garcia-Migue; Stephanía Cortes; Eduardo Agusti; Cristina Camacho; Yaowen Zhang; Yan Li; Sebastià Sabater; Aureli Torne; Meritxell Arenas
Journal:  J Contemp Brachytherapy       Date:  2018-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.